{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:15:35Z","timestamp":1789103735722,"version":"build-2803163510"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T00:00:00Z","timestamp":1599436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T00:00:00Z","timestamp":1599436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s11882-020-00960-2","type":"journal-article","created":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T02:02:15Z","timestamp":1599444135000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Safety of Intranasal Steroids: an Updated Perspective"],"prefix":"10.1007","volume":"20","author":[{"given":"John","family":"McDonnell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Weller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily C.","family":"Pien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,7]]},"reference":[{"issue":"10","key":"960_CR1","doi-asserted-by":"crossref","first-page":"992","DOI":"10.2174\/1389200218666161123123516","volume":"17","author":"TY Jang","year":"2016","unstructured":"Jang TY, Kim YH. Recent updates on the systemic and local safety of intranasal steroids. Curr Drug Metab. 2016;17(10):992\u20136.","journal-title":"Curr Drug Metab"},{"issue":"6 Suppl 2","key":"960_CR2","first-page":"S2","volume":"102","author":"GE D'Alonzo Jr","year":"2002","unstructured":"D'Alonzo GE Jr. Scope and impact of allergic rhinitis. J Am Osteopath Assoc. 2002;102(6 Suppl 2):S2\u20136.","journal-title":"J Am Osteopath Assoc"},{"issue":"5","key":"960_CR3","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2500\/aap.2012.33.3593","volume":"33","author":"JH van Bavel","year":"2012","unstructured":"van Bavel JH, Ratner PH, Amar NJ, Hampel FC Jr, Melchior A, Dunbar SA, et al. Efficacy and safety of once-daily treatment with beclomethasone dipropionate nasal aerosol in subjects with seasonal allergic rhinitis. Allergy Asthma Proc. 2012;33(5):386\u201396.","journal-title":"Allergy Asthma Proc"},{"issue":"6","key":"960_CR4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.anai.2017.08.012","volume":"119","author":"MS Dykewicz","year":"2017","unstructured":"\u2022 Dykewicz MS, Wallace DV, Baroody F, Bernstein J, Craig T, Finegold I, et al. Treatment of seasonal allergic rhinitis: an evidence-based focused 2017 guideline update. Ann Allergy Asthma Immunol. 2017;119(6):489\u2013511.e41 Important update for treatment of allergic rhinitis.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"960_CR5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.anai.2015.07.016","volume":"115","author":"P Badorrek","year":"2015","unstructured":"Badorrek P, Hohlfeld JM, Krug N, Joshi A, Raut A. Efficacy and safety of a novel nasal steroid, S0597, in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2015;115(4):325\u20139.e1.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"960_CR6","doi-asserted-by":"crossref","unstructured":"Thennati R, Khanna A, Khanna M, Sonaiya T, Mehta T, Mehta K, et al. Safety, tolerability, pharmacokinetics, and pharmacodynamics of compound SFDAC by intranasal administration of multiple escalating dose in healthy male subjects. Clin Pharmacol Drug Dev. 2014;3(6):428\u201338.","DOI":"10.1002\/cpdd.136"},{"issue":"5","key":"960_CR7","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.anai.2013.07.033","volume":"111","author":"WW Storms","year":"2013","unstructured":"Storms WW, Segall N, Mansfield LE, Amar NJ, Kelley L, Ding Y, et al. Efficacy and safety of beclomethasone dipropionate nasal aerosol in pediatric patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2013;111(5):408\u201314.e1.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"960_CR8","doi-asserted-by":"crossref","unstructured":"\u2022 Lightman S, Scadding GK. Should intranasal corticosteroids be used for the treatment of ocular symptoms of allergic rhinoconjunctivitis? A review of their efficacy and safety profile. Int Arch Allergy Immunol. 2012;158(4):317\u201325 Article reviewing ocular issues pertaining to INS.","DOI":"10.1159\/000333100"},{"issue":"6","key":"960_CR9","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2500\/aap.2011.32.3473","volume":"32","author":"MS Blaiss","year":"2011","unstructured":"Blaiss MS. Safety update regarding intranasal corticosteroids for the treatment of allergic rhinitis. Allergy Asthma Proc. 2011;32(6):413\u20138.","journal-title":"Allergy Asthma Proc"},{"issue":"5","key":"960_CR10","first-page":"445","volume":"64","author":"JH Day","year":"1990","unstructured":"Day JH, Andersson CB, Briscoe MP. Efficacy and safety of intranasal budesonide in the treatment of perennial rhinitis in adults and children. Ann Allergy. 1990;64(5):445\u201350.","journal-title":"Ann Allergy"},{"key":"960_CR11","doi-asserted-by":"crossref","unstructured":"Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, Brook I, Ashok Kumar K, Kramper M, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015;152(2 Suppl):S1\u2013S39.","DOI":"10.1177\/0194599815572097"},{"issue":"7","key":"960_CR12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11882-017-0720-3","volume":"17","author":"K Snidvongs","year":"2017","unstructured":"Snidvongs K, Thanaviratananich S. Update on intranasal medications in rhinosinusitis. Curr Allergy Asthma Rep. 2017 Jul;17(7):47.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"2","key":"960_CR13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0091-6749(91)90336-M","volume":"88","author":"HA Orgel","year":"1991","unstructured":"Orgel HA, Meltzer EO, Bierman CW, Bronsky E, Connell JT, Lieberman PL, et al. Intranasal fluocortin butyl in patients with perennial rhinitis: a 12-month efficacy and safety study including nasal biopsy. J Allergy Clin Immunol. 1991;88(2):257\u201364.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"960_CR14","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.anai.2013.09.003","volume":"111","author":"MS Blaiss","year":"2013","unstructured":"Blaiss MS. Over-the-counter intranasal corticosteroids: why the time is now. Pro Ann Allergy Asthma Immunol. 2013;111(5):316\u20138.","journal-title":"Pro Ann Allergy Asthma Immunol"},{"key":"960_CR15","doi-asserted-by":"crossref","unstructured":"Allen A, Murdoch RD, Bareille P, Burns O, Hughes S, Gupta A, et al. Pharmacokinetics, safety, and tolerability of once-daily intranasal fluticasone furoate and levocabastine administered alone or simultaneously as fluticasone furoate\/levocabastine fixed-dose combination. Clin Pharmacol Drug Dev. 2016 May;5(3):225\u201331.","DOI":"10.1002\/cpdd.218"},{"issue":"2","key":"960_CR16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2174\/1871523013666140826115204","volume":"13","author":"A Ahmadiafshar","year":"2014","unstructured":"Ahmadiafshar A, Ahmadiafshar S. Efficacy and safety of inhaled and intranasal corticosteroids. Antiinflamm Antiallergy Agents Med Chem. 2014;13(2):83\u20137.","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"key":"960_CR17","doi-asserted-by":"crossref","unstructured":"Davies RJ, Nelson HS. Once-daily mometasone furoate nasal spray: efficacy and safety of a new intranasal glucocorticoid for allergic rhinitis. Clin Ther. 1997;19(1):27\u201338.","DOI":"10.1016\/S0149-2918(97)80070-7"},{"issue":"1","key":"960_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5604\/00306657.1131143","volume":"69","author":"A Nowicka","year":"2015","unstructured":"Nowicka A, Samolinski B. Is the use of intranasal glucocorticosteroids (inGCSs) in children safe? Otolaryngol Pol. 2015;69(1):1\u201310.","journal-title":"Otolaryngol Pol"},{"issue":"1","key":"960_CR19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/00002018-200023010-00002","volume":"23","author":"BJ Lipworth","year":"2000","unstructured":"\u2022 Lipworth BJ, Jackson CM. Safety of inhaled and intranasal corticosteroids: lessons for the new millennium. Drug Saf. 2000;23(1):11\u201333 Broad review of the safety of INS.","journal-title":"Drug Saf"},{"issue":"2","key":"960_CR20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2500\/aap.2007.28.2948","volume":"28","author":"MS Blaiss","year":"2007","unstructured":"Blaiss MS. Safety considerations of intranasal corticosteroids for the treatment of allergic rhinitis. Allergy Asthma Proc. 2007;28(2):145\u201352.","journal-title":"Allergy Asthma Proc"},{"issue":"1","key":"960_CR21","first-page":"1","volume":"22","author":"J Sastre","year":"2012","unstructured":"Sastre J, Mosges R. Local and systemic safety of intranasal corticosteroids. J Investig Allergol Clin Immunol. 2012;22(1):1\u201312.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"6","key":"960_CR22","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S1081-1206(10)60373-0","volume":"99","author":"B Lanier","year":"2007","unstructured":"Lanier B, Kai G, Marple B, Wall GM. Pathophysiology and progression of nasal septal perforation. Ann Allergy Asthma Immunol. 2007;99(6):473\u20139 quiz 80\u20131, 521.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"960_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6815-7-1","volume":"7","author":"LK Dosen","year":"2007","unstructured":"Dosen LK, Haye R. Nasal septal perforation 1981\u20132005: changes in etiology, gender and size. BMC Ear Nose Throat Disord. 2007;7:1.","journal-title":"BMC Ear Nose Throat Disord"},{"issue":"12","key":"960_CR24","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2165\/00002018-200326120-00003","volume":"26","author":"RJ Salib","year":"2003","unstructured":"\u2022 Salib RJ, Howarth PH. Safety and tolerability profiles of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis. Drug Saf. 2003;26(12):863\u201393 Good review of safety of INS for particular populations (children, elderly, pregnancy).","journal-title":"Drug Saf"},{"issue":"6","key":"960_CR25","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.anai.2016.06.009","volume":"117","author":"GW Bensch","year":"2016","unstructured":"\u2022 Bensch GW. Safety of intranasal corticosteroids. Ann Allergy Asthma Immunol. 2016;117(6):601\u20135 Important overview article.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"960_CR26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1034\/j.1398-9995.2000.00370.x","volume":"55","author":"G Passalacqua","year":"2000","unstructured":"\u2022 Passalacqua G, Albano M, Canonica GW, Bachert C, Van Cauwenberge P, Davies RJ, et al. Inhaled and nasal corticosteroids: safety aspects. Allergy. 2000;55(1):16\u201333 Useful overview of safety of INS.","journal-title":"Allergy"},{"issue":"1","key":"960_CR27","first-page":"17","volume":"39","author":"JM Klossek","year":"2001","unstructured":"Klossek JM, Laliberte F, Laliberte MF, Mounedji N, Bousquet J. Local safety of intranasal triamcinolone acetonide: clinical and histological aspects of nasal mucosa in the long-term treatment of perennial allergic rhinitis. Rhinology. 2001;39(1):17\u201322.","journal-title":"Rhinology."},{"key":"960_CR28","unstructured":"Mehta DK. British National Formulary, number 432002 March 31, 2002."},{"issue":"5","key":"960_CR29","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/alr.21910","volume":"7","author":"J Manji","year":"2017","unstructured":"Manji J, Singh G, Okpaleke C, Dadgostar A, Al-Asousi F, Amanian A, et al. Safety of long-term intranasal budesonide delivered via the mucosal atomization device for chronic rhinosinusitis. Int Forum Allergy Rhinol. 2017;7(5):488\u201393.","journal-title":"Int Forum Allergy Rhinol"},{"key":"960_CR30","unstructured":"Welch MJ, Bronsky E, Findlay S, Pearlman DS, Southern DL, Storms WW, et al. Long-term safety of triamcinolone acetonide nasal aerosol for the treatment of perennial allergic rhinitis. Clin Ther. 1994;16(2):253\u201362."},{"issue":"1","key":"960_CR31","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1081-1206(10)63615-0","volume":"90","author":"DP Skoner","year":"2003","unstructured":"Skoner DP, Gentile D, Angelini B, Kane R, Birdsall D, Banerji D. The effects of intranasal triamcinolone acetonide and intranasal fluticasone propionate on short-term bone growth and HPA axis in children with allergic rhinitis. Ann Allergy Asthma Immunol. 2003 Jan;90(1):56\u201362.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"960_CR32","doi-asserted-by":"crossref","unstructured":"Schenkel EJ, Skoner DP, Bronsky EA, Miller SD, Pearlman DS, Rooklin A, et al. Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray. Pediatrics. 2000;105(2):E22.","DOI":"10.1542\/peds.105.2.e22"},{"issue":"6","key":"960_CR33","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1046\/j.1365-2222.2003.01689.x","volume":"33","author":"C Moller","year":"2003","unstructured":"Moller C, Ahlstrom H, Henricson KA, Malmqvist LA, Akerlund A, Hildebrand H. Safety of nasal budesonide in the long-term treatment of children with perennial rhinitis. Clin Exp Allergy. 2003;33(6):816\u201322.","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"960_CR34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2222.1982.tb03131.x","volume":"12","author":"JH Toogood","year":"1982","unstructured":"Toogood JH, Jennings B, Crepea SB, Johnson JD. Efficacy of safety of concurrent use of intranasal flunisolide and oral beclomethasone aerosols in treatment of asthmatics with rhinitis. Clin Allergy. 1982;12(1):95\u2013105.","journal-title":"Clin Allergy"},{"key":"960_CR35","doi-asserted-by":"crossref","unstructured":"Skoner DP, Rachelefsky GS, Meltzer EO, Chervinsky P, Morris RM, Seltzer JM, et al. Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate. Pediatrics. 2000;105(2):E23.","DOI":"10.1542\/peds.105.2.e23"},{"issue":"3","key":"960_CR36","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/00007611-200295030-00010","volume":"95","author":"LE Mansfield","year":"2002","unstructured":"Mansfield LE, Mendoza CP. Medium and long-term growth in children receiving intranasal beclomethasone dipropionate: a clinical experience. South Med J. 2002;95(3):334\u201340.","journal-title":"South Med J"},{"issue":"4","key":"960_CR37","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1081-1206(10)60340-7","volume":"102","author":"S Weinstein","year":"2009","unstructured":"Weinstein S, Qaqundah P, Georges G, Nayak A. Efficacy and safety of triamcinolone acetonide aqueous nasal spray in children aged 2 to 5 years with perennial allergic rhinitis: a randomized, double-blind, placebo-controlled study with an open-label extension. Ann Allergy Asthma Immunol. 2009;102(4):339\u201347.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"8","key":"960_CR38","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/j.clinthera.2007.08.017","volume":"29","author":"J Gradman","year":"2007","unstructured":"Gradman J, Caldwell MF, Wolthers OD. A 2-week, crossover study to investigate the effect of fluticasone furoate nasal spray on short-term growth in children with allergic rhinitis. Clin Ther. 2007 Aug;29(8):1738\u201347.","journal-title":"Clin Ther"},{"issue":"8","key":"960_CR39","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1080\/02770900701554359","volume":"44","author":"P Ratner","year":"2007","unstructured":"Ratner P, Darken P, Wingertzahn M, Shah T. Ciclesonide and beclomethasone dipropionate coadministration: effect on cortisol in perennial allergic rhinitis. J Asthma. 2007;44(8):629\u201333.","journal-title":"J Asthma"},{"key":"960_CR40","doi-asserted-by":"crossref","unstructured":"LaForce C, Journeay GE, Miller SD, Silvey MJ, Wu W, Lee LA, et al. Ocular safety of fluticasone furoate nasal spray in patients with perennial allergic rhinitis: a 2-year study. Ann Allergy Asthma Immunol. 2013;111(1):45\u201350.","DOI":"10.1016\/j.anai.2013.04.013"},{"issue":"2","key":"960_CR41","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2500\/ajra.2013.27.3864","volume":"27","author":"EO Meltzer","year":"2013","unstructured":"Meltzer EO, Bernstein DI, Prenner BM, Berger WE, Shekar T, Teper AA. Mometasone furoate nasal spray plus oxymetazoline nasal spray: short-term efficacy and safety in seasonal allergic rhinitis. Am J Rhinol Allergy. 2013;27(2):102\u20138.","journal-title":"Am J Rhinol Allergy"},{"key":"960_CR42","unstructured":"Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008;63(Suppl 86):8\u2013160."},{"issue":"12","key":"960_CR43","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2165\/00002018-200427120-00005","volume":"27","author":"CE Baena-Cagnani","year":"2004","unstructured":"\u2022\u2022 Baena-Cagnani CE. Safety and tolerability of treatments for allergic rhinitis in children. Drug Saf. 2004;27(12):883\u201398 Key review of the safety aspects of INS in children.","journal-title":"Drug Saf"},{"issue":"1 Suppl","key":"960_CR44","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1067\/mai.2001.115567","volume":"108","author":"J Dibildox","year":"2001","unstructured":"Dibildox J. Safety and efficacy of mometasone furoate aqueous nasal spray in children with allergic rhinitis: results of recent clinical trials. J Allergy Clin Immunol. 2001;108(1 Suppl):S54\u20138.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"960_CR45","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jaci.2016.01.021","volume":"138","author":"A Berard","year":"2016","unstructured":"Berard A, Sheehy O, Kurzinger ML, Juhaeri J. Intranasal triamcinolone use during pregnancy and the risk of adverse pregnancy outcomes. J Allergy Clin Immunol. 2016;138(1):97\u2013104 e7.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"960_CR46","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00405-017-4785-3","volume":"275","author":"AH Alhussien","year":"2018","unstructured":"\u2022 Alhussien AH, Alhedaithy RA, Alsaleh SA. Safety of intranasal corticosteroid sprays during pregnancy: an updated review. Eur Arch Otorhinolaryngol. 2018;275(2):325\u201333 Key review of safety of INS in pregnancy.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"6","key":"960_CR47","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1468-1293.2008.00579.x","volume":"9","author":"MM Foisy","year":"2008","unstructured":"\u2022 Foisy MM, Yakiwchuk EM, Chiu I, Singh AE. Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature. HIV Med. 2008;9(6):389\u201396 Looks at issues with INS in HIV+ populations.","journal-title":"HIV Med"},{"issue":"9","key":"960_CR48","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/jama.1997.03540330044033","volume":"277","author":"E Garbe","year":"1997","unstructured":"Garbe E, LeLorier J, Boivin JF, Suissa S. Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma. JAMA. 1997;277(9):722\u20137.","journal-title":"JAMA"},{"issue":"5","key":"960_CR49","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.anai.2010.03.007","volume":"104","author":"J Grossman","year":"2010","unstructured":"Grossman J, Gates D. Mometasone furoate nasal spray for the treatment of elderly patients with perennial allergic rhinitis. Ann Allergy Asthma Immunol. 2010 May;104(5):452\u20133.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"960_CR50","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1081-1206(10)62057-1","volume":"91","author":"MS Dykewicz","year":"2003","unstructured":"\u2022 Dykewicz MS, Kaiser HB, Nathan RA, Goode-Sellers S, Cook CK, Witham LA, et al. Fluticasone propionate aqueous nasal spray improves nasal symptoms of seasonal allergic rhinitis when used as needed (prn). Ann Allergy Asthma Immunol. 2003;91(1):44\u20138 Article showing some efficacy of INS even given PRN.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"960_CR51","first-page":"648","volume":"118","author":"E Minshall","year":"1998","unstructured":"Minshall E, Ghaffar O, Cameron L, O'Brien F, Quinn H, Rowe-Jones J, et al. Assessment by nasal biopsy of long-term use of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitis. Otolaryngol Head Neck Surg. 1998;118(5):648\u201354.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"3","key":"960_CR52","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2222.1988.tb02867.x","volume":"18","author":"U Pipkorn","year":"1988","unstructured":"Pipkorn U, Pukander J, Suonpaa J, Makinen J, Lindqvist N. Long-term safety of budesonide nasal aerosol: a 5.5-year follow-up study. Clin Allergy. 1988;18(3):253\u20139.","journal-title":"Clin Allergy"},{"key":"960_CR53","first-page":"CD011993","volume":"4","author":"LY Chong","year":"2016","unstructured":"Chong LY, Head K, Hopkins C, Philpott C, Burton MJ, Schilder AG. Different types of intranasal steroids for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016;4:CD011993.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6 Suppl 1","key":"960_CR54","first-page":"S5","volume":"22","author":"MS Blaiss","year":"2001","unstructured":"\u2022 Blaiss MS. Efficacy, safety, and patient preference of inhaled nasal corticosteroids: a review of pertinent published data. Allergy Asthma Proc. 2001;22(6 Suppl 1):S5\u201310 Review of published studies on safety.","journal-title":"Allergy Asthma Proc"},{"key":"960_CR55","doi-asserted-by":"crossref","unstructured":"\u2022 Khanna P, Shah A. Assessment of sensory perceptions and patient preference for intranasal corticosteroid sprays in allergic rhinitis. Am J Rhinol. 2005;19(3):316\u201321 Details how sensory aspects differ between medications.","DOI":"10.1177\/194589240501900318"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-020-00960-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11882-020-00960-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-020-00960-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T23:36:00Z","timestamp":1630971360000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11882-020-00960-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,7]]},"references-count":55,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["960"],"URL":"https:\/\/doi.org\/10.1007\/s11882-020-00960-2","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,7]]},"assertion":[{"value":"7 September 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"69"}}